Anabolics vs. Mitochondrial Peptides: Performance Evidence

Why This Comparison Is Lopsided

If your only goal is to pack on as much raw mass as possible, this isn't much of a comparison. Traditional anabolic steroids (AAS) win that contest in randomized human trials, and mitochondrial peptides have no comparable data. Comparing something like MOTS-c to a gram of testosterone for pure hypertrophy is like comparing a torque wrench to a sledgehammer. They're built for entirely different tasks.

So why are we even talking about them in the same article? Because lifters and endurance athletes do compare them, usually on endurance and recovery rather than size. The useful question isn't "which one is better," it's what performance outcomes have actually been measured for each, and in whom. For the mechanism contrast itself, see our comparative analysis of anabolics and mitochondrial peptides.

How Anabolics Add Muscle

Most lifters know how anabolics work, at least in broad strokes. You introduce a compound like testosterone or one of its derivatives, it binds to the androgen receptor (AR) in your muscle cells, and that complex travels to the nucleus to directly influence gene expression. The result is a large increase in muscle protein synthesis and nitrogen retention. You're telling your body to build more tissue, faster.

The human data are direct. In a 1996 New England Journal of Medicine trial, 43 healthy men were randomly assigned to weekly injections of 600 mg of testosterone enanthate or placebo for 10 weeks, with or without weight training. Men given testosterone plus training gained about 6.1 kg of fat-free mass, and their bench press rose about 22 kg. A 2001 follow-up in 61 young men found the gain in fat-free mass scaled with dose, reaching about 7.9 kg over 20 weeks at 600 mg a week.

It's a brute-force approach, and it works for adding size and strength. The downside, of course, is that the androgen receptor is everywhere. Activating it in your scalp, prostate and heart, and shutting down your own natural hormone production (HPTA suppression), comes with a well-documented list of side effects; in the 2001 study, HDL cholesterol fell as the dose rose. You're swinging a hammer that hits more than the nail you're aiming for. Endurance is a different story: the classic testosterone trials measured lean mass and strength, not endurance or fatigue.

The Mitochondrial Engineer: Upgrading the Power Plant

Mitochondrial peptides like MOTS-c and SS-31 couldn't care less about the androgen receptor. They don't directly trigger protein synthesis in the same way. Instead, they operate on your cellular power plants, the mitochondria.

MOTS-c: The "Exercise in a Bottle" Signal

MOTS-c is a peptide that's actually encoded in your mitochondrial DNA. When you exercise, your levels of it naturally increase in muscle and blood. In cell and mouse studies, it activates a metabolic sensor called AMP-activated protein kinase (AMPK). This is the same pathway that gets flipped on during intense training or fasting.

In mice, activating AMPK this way boosted glucose uptake into muscles and increased fatty acid oxidation (burning fat for fuel). In essence, MOTS-c sends a signal that mimics some metabolic effects of endurance exercise. A 2015 Cell Metabolism study found it reduced diet-induced obesity and insulin resistance in mice, and a 2021 Nature Communications study found it improved running capacity in mice of several ages. You're not necessarily building a bigger muscle fiber, you're making the existing fiber function better. As of October 2026, though, no peer-reviewed study has given native MOTS-c to people. For more on the mouse data, see our article on MOTS-c for endurance.

SS-31: The Mitochondrial Bodyguard

SS-31 (also known as elamipretide) has a different, more targeted job. Over time, mitochondrial membranes take a beating from oxidative stress. Specifically, a phospholipid called cardiolipin on the inner mitochondrial membrane gets damaged. When cardiolipin is compromised, the whole energy production process becomes leaky and inefficient.

SS-31 is a tiny, four-amino-acid peptide that selectively targets the inner mitochondrial membrane and binds to cardiolipin. In lab and animal studies it protected cardiolipin from oxidative damage and helped restore its structure. Think of it as a bodyguard that goes directly to the most vulnerable part of your cellular engine and shields it from damage. In those models this led to more efficient ATP production; whether it means better recovery in people is untested.

Neither of these peptides is "anabolic" in the traditional sense. They are metabolic regulators and cyto-protectants. They don't build a bigger house; they're meant to improve the wiring and plumbing in the house you have.

Performance Outcomes: What Has Been Measured

The best way to see the difference is to lay it out side-by-side, with the type of evidence behind each cell.

For SS-31, the details matter. MMPOWER-3, a Phase 3 trial in 218 adults with primary mitochondrial myopathy, gave 40 mg a day by subcutaneous injection for 24 weeks and missed both primary endpoints, 6-minute walk distance and fatigue. In heart failure, the 71-patient PROGRESS-HF trial found no change in heart volume after 4 weeks at 4 or 40 mg daily.

On September 19, 2025, the FDA granted elamipretide accelerated approval as Forzinity, a prescription medicine for Barth syndrome, a rare mitochondrial disease. According to the FDA's Drug Trials Snapshot, its 12-patient trial missed its primary endpoints (walking distance and fatigue) in the randomized phase; the approval rests on knee strength gains seen later, in the open-label extension, and a confirmatory trial is required. As of October 2026, that is the strongest human strength signal for any mitochondrial peptide, and it comes from people with a severe disease, not healthy athletes.

What Users Report and What's Untested

On forums, some lifters describe adding SS-31 during heavy training blocks, and others use MOTS-c during contest prep hoping for better insulin sensitivity and fat loss. Some report more endurance; others notice nothing. No study has tested either peptide in people who also use anabolics. For endurance athletes or people focused on health and longevity, traditional anabolics are probably off the table entirely, but the case for mitochondrial peptides still rests on mouse data.

As of October 2026, WADA's 2026 Prohibited List bans anabolic agents and names MOTS-c under S4.4.1; SS-31's status since its approval is unverified. See why mitochondrial peptides are off-limits in sport.

What We Still Don't Know

• Whether MOTS-c changes strength or endurance in any human, and whether the Forzinity knee-strength result holds up in its confirmatory trial.
• How either compares head to head with anabolics. Nobody has run that trial. For which outcomes were measured in which populations, see mitochondrial peptides vs. steroids: comparative efficacy.